Collision tumors are defined as the presence of two contiguous histologically different lesions composed of benign and/or malignant components. They are infrequent entities and have been reported in various organs and systems. The most common type of collision tumor in the adrenal gland is the association of two benign lesions, adenoma and myelolipoma. Modification in image characteristics or unexpected growth of an adrenal tumor previously characterized as a benign lesion should be suspicious for collision tumor with a new aggressive component. In this article, we present a case of renal carcinoma metastasis within a previously known adrenal adenoma.
A 58-year-old female patient, former smoker, was on oncological follow-up due to clear renal cell carcinoma in the right kidney. Total nephrectomy was performed in September 2011. As an incidental finding at that time, the patient also presented a well-defined nodule in the left adrenal gland on a magnetic resonance imaging (MRI) scan in keeping with adenoma and measuring 3.0 cm in diameter ( Figure 1 ). An abdominal computed tomography (CT) performed in September 2013 showed a slight increase in size of the left adrenal gland nodule, with 3.5 cm in diameter at this moment. In addition, a small soft tissue density nodule with intense contrast enhancement arose within it, measuring 1.5 cm (Figure 2 ). Right adrenal gland and left kidney had usual tomographic appearance. The hypothesis of a metastatic implant within the previously known adrenal adenoma was suggested. A MRI study confirmed the presence of the hypervascular lesion within the left adrenal adenoma. The new component showed restriction of water diffusion and absence of signal loss in out-of-phase images, which indicate hypercellularity and lack of intracellular fat, respectively, opposite characteristics compared to those presented by other portions of the adrenal adenoma ( Figure 3) . Based on these findings, left adrenalectomy was performed in December 2013. In accordance with the imaging findings, histopathological study described renal cell carcinoma metastasis within the adrenal adenoma, which is indicative of collision tumor. The patient remains under clinical and radiological periodic monitoring. To date, there is no evidence of abdominal recurrence.
Adrenal cortical adenoma is the most common tumor of the adrenal gland, with an estimated prevalence of 1.4% to 8.9% based on autopsy series 1 . They are characteristically well-demarcated lesions composed of water and fat, the latter predominantly intracellular 1, 2 . Collision tumors are uncommon entities defined by the presence of two contiguous histologically different lesions, described in various locations, such as central nervous system, breast, lung, adrenal gland, and others 2, 3 . They may be composed of two benign or two malignant lesions, or a benign tumor with a malignant lesion 4 . In the adrenal gland, the most common type of collision tumor is the association of adenoma and myelolipoma 4 . Adrenal metastatic implants are typically originated by lung carcinoma, breast carcinoma, or melanoma 1, 3, 4 . CT can show differences in attenuation and enhancement between the lesions 1, 3 . The growth of a lesion previously characterized as adrenal adenoma should also be suspicious of collision tumors with a new more aggressive component, such as adrenal metastasis, adrenal carcinoma, or pheochromocytoma 3 . Chemical shift MRI properties can assess the presence of intracellular fat, a feature typically associated with adenomas [1] [2] [3] [4] [5] . The absence of signal loss in out-of-phase images in some portion of an adenoma should raise the possibility of secondary neoplastic implants, especially in patients with known extra-adrenal cancer 1, 2 . Special attention should be given to renal cell carcinoma: due to varying amounts of cytoplasmic fat, it can present signal loss similar to adenomas 5 . In these cases, other parameters must be considered, such as growth and enhancement kinetics 5 .
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